Fluorodeoxyglucose PET in Radiation Oncology Planning
Ria Brown1, Jay Garlapati1, Soumon Rudra1
1Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Abstract:
Fluorodeoxyglucose (FDG) PET is a critical functional imaging modality in modern radiation therapy, enabling improved tumor detection, target delineation, and treatment assessment. This review highlights FDG-PET's role in radiotherapy planning, including integration through image registration, PET/computed tomography simulation, and incorporation of quantitative metrics for segmentation and dose optimization. Emerging applications such as adaptive radiotherapy and dose painting are discussed, along with using FDG-PET to assess treatment response. FDG-PET also provides insight into radiation-induced normal tissue changes and prior treatment fields. Collectively, FDG-PET enhances precision in radiotherapy planning and supports more personalized, response-adaptive treatment strategies.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET


